Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
Läubli HBC, Bossard M, Pfister O et al. Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma. J Immunother Cancer 2015; 3: 11
Drug-induced myocarditis after nivolumab treatment in a patient with PDL1-negative squamous cell carcinoma of the lung
Semper H, Muehlberg F, Schulz-Menger J et al. Drug-induced myocarditis after nivolumab treatment in a patient with PDL1-negative squamous cell carcinoma of the lung. Lung Cancer 2016; 99: 117-119
Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma
Mehta A, Gupta A, Hannallah F et al. Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma. Melanoma Res 2016; 26: 319-320
Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: A case of takotsubolike syndrome
Geisler BP, Raad RA, Esaian D et al. Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: A case of takotsubolike syndrome. J Immunother Cancer. 2015; 3: 4
Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
Zimmer L, Goldinger SM, Hofmann L et al. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. Eur J Cancer 2016; 60: 210-225
Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for nonsmall cell lung cancer
Gibson R, Delaune J, Szady A et al. Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for nonsmall cell lung cancer. BMJ Case Rep 2016; 2016
